Last Price$175.61.0%
Market Cap$411.8B
P/EBITDA LTM
17.9x
5Y avg
18.6x
Household & Personal Products industry
median
7.8x
Stock quality & Intrinsic value
7/10
(0.2%) overvalued
The Procter & Gamble Company P/EBITDA LTM
Annual
Quarterly
Daily
Crunching data... Almost there!
| Jun'05 | Jun'06 | Jun'07 | Jun'08 | Jun'09 | Jun'10 | Jun'11 | Jun'12 | Jun'13 | Jun'14 | Jun'15 | Jun'16 | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/EBITDA LTM | 10.5x | 12.2x | 10.5x | 9.4x | 7.9x | 8.7x | 9.4x | 10.1x | 11.6x | 12.5x | 14.2x | 14.8x | 13.9x | 11.7x | 16.2x | 27.9x | 16.1x | 16.1x | 16.7x | 17.0x |
Overvalued or undervalued?
Check the intrinsic value for PG
and see if it's the right time to invest.
The Procter & Gamble Company (PG) P/EBITDA LTM comparison analysis
General
LTM P/EBITDA LTM
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
The Procter & Gamble CompanyPG
17.7x
2.5%
3.8%
17.7%
Median Peer Set
17.6x
2.6%
(17.5%)
8.1%
Hims & Hers Health, Inc.HIMS
127.0x
65.5%
(65.6%)
(2.7%)
The Estée Lauder Companies Inc.EL
71.1x
(1.9%)
(61.2%)
2.5%
Church & Dwight Co., Inc.CHD
27.8x
4.1%
(22.7%)
9.6%
e.l.f. Beauty, Inc.ELF
22.6x
76.9%
99.1%
12.5%
The Clorox CompanyCLX
20.0x
(4.0%)
86.0%
3.9%
Colgate-Palmolive CompanyCL
15.2x
3.3%
27.0%
14.4%
Kenvue Inc.KVUE
14.4x
0.1%
(40.0%)
6.7%
Kimberly-Clark CorporationKMB
12.7x
(1.8%)
45.5%
12.7%
Coty Inc.COTY
6.5x
10.2%
(85.0%)
1.5%
Unilever PLCUL
5.7x
1.8%
(12.4%)
10.9%
PG key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Jun'05 | Jun'06 | Jun'07 | Jun'08 | Jun'09 | Jun'10 | Jun'11 | Jun'12 | Jun'13 | Jun'14 | Jun'15 | Jun'16 | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 56,741.0 10.4% | 68,222.0 20.2% | 76,476.0 12.1% | 81,748.0 6.9% | 76,694.0 (6.2%) | 77,567.0 1.1% | 81,104.0 4.6% | 82,006.0 1.1% | 80,116.0 (2.3%) | 74,401.0 (7.1%) | 70,749.0 (4.9%) | 65,299.0 (7.7%) | 65,058.0 (0.4%) | 66,832.0 2.7% | 67,684.0 1.3% | 70,950.0 4.8% | 76,118.0 7.3% | 80,187.0 5.3% | 82,006.0 2.3% | 84,039.0 2.5% |
| Cost of Goods Sold (COGS) | 27,872.0 | 33,125.0 | 36,686.0 | 39,536.0 | 38,690.0 | 37,042.0 | 39,859.0 | 41,411.0 | 39,991.0 | 39,030.0 | 37,056.0 | 32,909.0 | 32,638.0 | 34,432.0 | 34,768.0 | 35,250.0 | 37,108.0 | 42,157.0 | 42,760.0 | 40,848.0 |
% margin | 28,869.0 50.9% | 35,097.0 51.4% | 39,790.0 52.0% | 42,212.0 51.6% | 38,004.0 49.6% | 40,525.0 52.2% | 41,245.0 50.9% | 40,595.0 49.5% | 40,125.0 50.1% | 35,371.0 47.5% | 33,693.0 47.6% | 32,390.0 49.6% | 32,420.0 49.8% | 32,400.0 48.5% | 32,916.0 48.6% | 35,700.0 50.3% | 39,010.0 51.2% | 38,030.0 47.4% | 39,246.0 47.9% | 43,191.0 51.4% |
| Operating Expenses | 18,400.0 | 21,848.0 | 24,340.0 | 25,575.0 | 22,630.0 | 24,793.0 | 25,750.0 | 27,560.0 | 26,308.0 | 21,461.0 | 22,644.0 | 18,949.0 | 18,654.0 | 19,037.0 | 27,429.0 | 19,994.0 | 21,024.0 | 20,217.0 | 21,112.0 | 24,646.0 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, General & Administrative Expenses (SG&A) | 18,400.0 | 21,848.0 | 24,340.0 | 25,575.0 | 22,630.0 | 24,793.0 | 25,750.0 | 25,984.0 | 26,000.0 | 21,461.0 | 20,616.0 | 18,949.0 | 18,654.0 | 19,037.0 | 19,084.0 | 19,994.0 | 21,024.0 | 20,217.0 | 21,112.0 | 23,305.0 |
% margin | 10,469.0 18.5% | 13,249.0 19.4% | 15,450.0 20.2% | 16,637.0 20.4% | 15,374.0 20.0% | 15,732.0 20.3% | 15,495.0 19.1% | 13,035.0 15.9% | 13,817.0 17.2% | 13,910.0 18.7% | 11,049.0 15.6% | 13,441.0 20.6% | 13,766.0 21.2% | 13,363.0 20.0% | 5,487.0 8.1% | 15,706.0 22.1% | 17,986.0 23.6% | 17,813.0 22.2% | 18,134.0 22.1% | 18,545.0 22.1% |
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 62.0 | 77.0 | 88.0 | 99.0 | 149.0 | 182.0 | 171.0 | 247.0 | 220.0 | 155.0 | 45.0 | 51.0 | 307.0 | 473.0 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 1,467.0 | 1,358.0 | 946.0 | 831.0 | 769.0 | 667.0 | 709.0 | 626.0 | 579.0 | 465.0 | 506.0 | 509.0 | 465.0 | 502.0 | 439.0 | 756.0 | 925.0 |
| Pre-tax Income | 9,981.0 | 12,413.0 | 14,710.0 | 15,632.0 | 14,413.0 | 14,868.0 | 14,997.0 | 12,528.0 | 14,179.0 | 13,509.0 | 11,012.0 | 13,369.0 | 13,257.0 | 13,326.0 | 6,069.0 | 15,834.0 | 17,615.0 | 17,995.0 | 18,353.0 | 18,761.0 |
% effective tax rate | 3,058.0 30.6% | 3,729.0 30.0% | 4,370.0 29.7% | 3,834.0 24.5% | 3,733.0 25.9% | 4,017.0 27.0% | 3,299.0 22.0% | 3,378.0 27.0% | 3,226.0 22.8% | 2,851.0 21.1% | 2,725.0 24.7% | 3,342.0 25.0% | 3,063.0 23.1% | 3,465.0 26.0% | 2,103.0 34.7% | 2,731.0 17.2% | 3,263.0 18.5% | 3,202.0 17.8% | 3,615.0 19.7% | 3,787.0 20.2% |
% margin | 6,923.0 12.2% | 8,684.0 12.7% | 10,340.0 13.5% | 12,075.0 14.8% | 13,436.0 17.5% | 12,736.0 16.4% | 11,797.0 14.5% | 10,756.0 13.1% | 11,312.0 14.1% | 11,643.0 15.6% | 7,036.0 9.9% | 10,508.0 16.1% | 15,326.0 23.6% | 9,750.0 14.6% | 3,897.0 5.8% | 13,027.0 18.4% | 14,306.0 18.8% | 14,742.0 18.4% | 14,653.0 17.9% | 14,879.0 17.7% |
| EPS | 2.70 | 2.79 | 3.22 | 3.86 | 4.49 | 4.32 | 4.12 | 3.82 | 4.04 | 4.19 | 2.50 | 3.80 | 5.80 | 3.85 | 1.56 | 5.13 | 5.69 | 6.00 | 6.07 | 6.30 |
| Diluted EPS | 2.53 | 2.64 | 3.04 | 3.64 | 4.26 | 4.11 | 3.93 | 3.66 | 3.86 | 4.01 | 2.44 | 3.69 | 5.59 | 3.67 | 1.53 | 4.96 | 5.50 | 5.81 | 5.90 | 6.02 |
% margin | 12,353.0 21.8% | 15,876.0 23.3% | 18,580.0 24.3% | 20,265.0 24.8% | 18,853.0 24.6% | 18,922.0 24.4% | 18,666.0 23.0% | 16,501.0 20.1% | 17,828.0 22.3% | 17,359.0 23.3% | 14,772.0 20.9% | 17,026.0 26.1% | 16,542.0 25.4% | 16,666.0 24.9% | 9,402.0 13.9% | 19,312.0 27.2% | 20,852.0 27.4% | 21,241.0 26.5% | 21,823.0 26.6% | 22,582.0 26.9% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is The Procter & Gamble Company's P/EBITDA LTM?
As of today, Microsoft Corp's last 12-month P/EBITDA LTM is 17.9x, based on the financial report for Dec 30, 2024 (Q4’2024). The average annual P/EBITDA LTM for The Procter & Gamble Company have been 16.8x over the past three years, and 19.5x over the past five years.
2) Is The Procter & Gamble Company's P/EBITDA LTM Good?
As of today, The Procter & Gamble Company's P/EBITDA LTM is 17.9x, which is higher than industry median of 7.8x. It indicates that The Procter & Gamble Company's P/EBITDA LTM is Bad.